img

Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) key companies include Aeolus Pharmaceuticals, Inc., Atox Bio Ltd, BCN Biosciences LLC, Cellphire Inc, Daiichi Sankyo Co Ltd, FirstString Research Inc, RxBio Inc and Shuttle Pharmaceuticals LLC, etc. Aeolus Pharmaceuticals, Inc., Atox Bio Ltd, BCN Biosciences LLC are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market and estimated to attract more attentions from industry insiders and investors.
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) can be divided into Blood Transfusion, Antibiotic and Others,, etc. Blood Transfusion is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) is widely used in various fields, such as Hospital and Clinic, etc. Hospital provides greatest supports to the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) industry development. In 2022, global % revenue of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) went into Hospital filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Aeolus Pharmaceuticals, Inc.
Atox Bio Ltd
BCN Biosciences LLC
Cellphire Inc
Daiichi Sankyo Co Ltd
FirstString Research Inc
RxBio Inc
Shuttle Pharmaceuticals LLC
Segment by Type
Blood Transfusion
Antibiotic
Others

Segment by Application


Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) introduction, etc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Blood Transfusion
1.2.3 Antibiotic
1.2.4 Others
1.3 Market by Application
1.3.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Perspective (2018-2033)
2.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Trends by Region
2.2.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Region (2018-2023)
2.2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Region (2024-2033)
2.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Dynamics
2.3.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry Trends
2.3.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
2.3.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
2.3.4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) by Players
3.1.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Players (2018-2023)
3.1.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Players (2018-2023)
3.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio
3.4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue in 2022
3.5 Global Key Players of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Head office and Area Served
3.6 Global Key Players of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), Product and Application
3.7 Global Key Players of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Type
4.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Type (2018-2023)
4.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2024-2033)
5 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Breakdown Data by Application
5.1 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Historic Market Size by Application (2018-2023)
5.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2033)
6.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
6.2.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023)
6.2.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2024-2033)
6.2.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2018-2033)
6.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
6.3.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023)
6.3.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2024-2033)
6.3.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2018-2033)
6.4 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
6.4.1 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2018-2023)
6.4.3 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2033)
7.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
7.2.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023)
7.2.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2024-2033)
7.2.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2018-2033)
7.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
7.3.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023)
7.3.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2024-2033)
7.3.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2018-2033)
7.4 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
7.4.1 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2018-2023)
7.4.3 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2033)
8.2 China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
8.2.1 China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023)
8.2.2 China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2024-2033)
8.2.3 China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2018-2033)
8.3 China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
8.3.1 China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023)
8.3.2 China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2024-2033)
8.3.3 China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2033)
9.2 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
9.2.1 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023)
9.2.2 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2024-2033)
9.2.3 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2018-2033)
9.3 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
9.3.1 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023)
9.3.2 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2024-2033)
9.3.3 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2018-2033)
9.4 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region
9.4.1 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2018-2023)
9.4.3 Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Aeolus Pharmaceuticals, Inc.
11.1.1 Aeolus Pharmaceuticals, Inc. Company Details
11.1.2 Aeolus Pharmaceuticals, Inc. Business Overview
11.1.3 Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.1.4 Aeolus Pharmaceuticals, Inc. Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
11.1.5 Aeolus Pharmaceuticals, Inc. Recent Developments
11.2 Atox Bio Ltd
11.2.1 Atox Bio Ltd Company Details
11.2.2 Atox Bio Ltd Business Overview
11.2.3 Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.2.4 Atox Bio Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
11.2.5 Atox Bio Ltd Recent Developments
11.3 BCN Biosciences LLC
11.3.1 BCN Biosciences LLC Company Details
11.3.2 BCN Biosciences LLC Business Overview
11.3.3 BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.3.4 BCN Biosciences LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
11.3.5 BCN Biosciences LLC Recent Developments
11.4 Cellphire Inc
11.4.1 Cellphire Inc Company Details
11.4.2 Cellphire Inc Business Overview
11.4.3 Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.4.4 Cellphire Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
11.4.5 Cellphire Inc Recent Developments
11.5 Daiichi Sankyo Co Ltd
11.5.1 Daiichi Sankyo Co Ltd Company Details
11.5.2 Daiichi Sankyo Co Ltd Business Overview
11.5.3 Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.5.4 Daiichi Sankyo Co Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
11.5.5 Daiichi Sankyo Co Ltd Recent Developments
11.6 FirstString Research Inc
11.6.1 FirstString Research Inc Company Details
11.6.2 FirstString Research Inc Business Overview
11.6.3 FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.6.4 FirstString Research Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
11.6.5 FirstString Research Inc Recent Developments
11.7 RxBio Inc
11.7.1 RxBio Inc Company Details
11.7.2 RxBio Inc Business Overview
11.7.3 RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.7.4 RxBio Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
11.7.5 RxBio Inc Recent Developments
11.8 Shuttle Pharmaceuticals LLC
11.8.1 Shuttle Pharmaceuticals LLC Company Details
11.8.2 Shuttle Pharmaceuticals LLC Business Overview
11.8.3 Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Introduction
11.8.4 Shuttle Pharmaceuticals LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
11.8.5 Shuttle Pharmaceuticals LLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Antibiotic
Table 4. Key Players of Others
Table 5. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Region (2018-2023)
Table 9. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Region (2024-2033)
Table 11. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Trends
Table 12. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Drivers
Table 13. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Challenges
Table 14. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Restraints
Table 15. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Players (2018-2023)
Table 17. Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) as of 2022)
Table 18. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), Headquarters and Area Served
Table 21. Global Key Players of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), Product and Application
Table 22. Global Key Players of Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome), Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Type (2018-2023)
Table 26. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Market Share by Type (2024-2033)
Table 28. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Application (2018-2023)
Table 30. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue Share by Application (2024-2033)
Table 32. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size by Country (2024-2033) & (US$ Million)
Table 64. Aeolus Pharmaceuticals, Inc. Company Details
Table 65. Aeolus Pharmaceuticals, Inc. Business Overview
Table 66. Aeolus Pharmaceuticals, Inc. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 67. Aeolus Pharmaceuticals, Inc. Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023) & (US$ Million)
Table 68. Aeolus Pharmaceuticals, Inc. Recent Developments
Table 69. Atox Bio Ltd Company Details
Table 70. Atox Bio Ltd Business Overview
Table 71. Atox Bio Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 72. Atox Bio Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023) & (US$ Million)
Table 73. Atox Bio Ltd Recent Developments
Table 74. BCN Biosciences LLC Company Details
Table 75. BCN Biosciences LLC Business Overview
Table 76. BCN Biosciences LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 77. BCN Biosciences LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023) & (US$ Million)
Table 78. BCN Biosciences LLC Recent Developments
Table 79. Cellphire Inc Company Details
Table 80. Cellphire Inc Business Overview
Table 81. Cellphire Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 82. Cellphire Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023) & (US$ Million)
Table 83. Cellphire Inc Recent Developments
Table 84. Daiichi Sankyo Co Ltd Company Details
Table 85. Daiichi Sankyo Co Ltd Business Overview
Table 86. Daiichi Sankyo Co Ltd Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 87. Daiichi Sankyo Co Ltd Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023) & (US$ Million)
Table 88. Daiichi Sankyo Co Ltd Recent Developments
Table 89. FirstString Research Inc Company Details
Table 90. FirstString Research Inc Business Overview
Table 91. FirstString Research Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 92. FirstString Research Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023) & (US$ Million)
Table 93. FirstString Research Inc Recent Developments
Table 94. RxBio Inc Company Details
Table 95. RxBio Inc Business Overview
Table 96. RxBio Inc Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 97. RxBio Inc Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023) & (US$ Million)
Table 98. RxBio Inc Recent Developments
Table 99. Shuttle Pharmaceuticals LLC Company Details
Table 100. Shuttle Pharmaceuticals LLC Business Overview
Table 101. Shuttle Pharmaceuticals LLC Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Product
Table 102. Shuttle Pharmaceuticals LLC Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023) & (US$ Million)
Table 103. Shuttle Pharmaceuticals LLC Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type: 2022 VS 2033
Figure 3. Blood Transfusion Features
Figure 4. Antibiotic Features
Figure 5. Others Features
Figure 6. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Report Years Considered
Figure 11. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Region: 2022 VS 2033
Figure 14. Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Players in 2022
Figure 15. Global Top Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue in 2022
Figure 17. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2018-2033)
Figure 19. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2018-2033)
Figure 20. North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Country (2018-2033)
Figure 21. United States Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY (2018-2033) & (US$ Million)
Figure 24. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2018-2033)
Figure 25. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2018-2033)
Figure 26. Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Country (2018-2033)
Figure 27. Germany Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY (2018-2033) & (US$ Million)
Figure 34. China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2018-2033)
Figure 35. China Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2018-2033)
Figure 36. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY (2018-2033) & (US$ Million)
Figure 37. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2018-2033)
Figure 38. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2018-2033)
Figure 39. Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Region (2018-2033)
Figure 40. Japan Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. South Korea Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. China Taiwan Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Type (2018-2033)
Figure 48. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Application (2018-2033)
Figure 49. Middle East, Africa, and Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Share by Country (2018-2033)
Figure 50. Brazil Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Mexico Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Turkey Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Israel Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. GCC Countries Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. South Africa Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Revenue (2018-2033) & (US$ Million)
Figure 57. Aeolus Pharmaceuticals, Inc. Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
Figure 58. Atox Bio Ltd Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
Figure 59. BCN Biosciences LLC Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
Figure 60. Cellphire Inc Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
Figure 61. Daiichi Sankyo Co Ltd Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
Figure 62. FirstString Research Inc Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
Figure 63. RxBio Inc Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
Figure 64. Shuttle Pharmaceuticals LLC Revenue Growth Rate in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed